Join Michael Fenn, PhD, and Troy Norris, MBA, as we look at how to begin planning an R&D pipeline and development strategy for both pre-clinical and clinical studies, as well as considerations of different regulatory pathways. We will also look at how to perform an initial risk assessment and commercial readiness assessment.